Headlines about Unilife Corp (NASDAQ:UNIS) have trended somewhat positive on Friday, AlphaOne Sentiment reports. AlphaOne, a division of Accern, identifies negative and positive press coverage by monitoring more than 20 million news and blog sources in real time. AlphaOne ranks coverage of public companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Unilife Corp earned a news impact score of 0.14 on AlphaOne’s scale. AlphaOne also gave news stories about the medical instruments supplier an impact score of 100 out of 100, meaning that recent press coverage is extremely likely to have an impact on the stock’s share price in the near term.

These are some of the news stories that may have impacted Alpha One Sentiment’s analysis:

Shares of Unilife Corp (NASDAQ:UNIS) traded up 0.0000% on Friday, hitting $0.1591. The stock has a 50-day moving average price of $1.28 and a 200 day moving average price of $2.05. Unilife Corp has a one year low of $0.09 and a one year high of $6.20. The stock’s market cap is $2.65 million.

COPYRIGHT VIOLATION WARNING: This news story was originally published by Financial Market News and is owned by of Financial Market News. If you are viewing this news story on another website, it was illegally stolen and republished in violation of United States & international trademark and copyright law. The legal version of this news story can be viewed at https://www.financial-market-news.com/2017/04/21/unilife-corp-unis-earns-daily-media-impact-score-of-0-14.html.

About Unilife Corp

Unilife Corp is engaged in the designing, development and manufacturing of injectable drug delivery systems. The Company has a portfolio of product platforms, including pre-filled syringes, disposable and reusable auto-injectors, drug reconstitution delivery systems, ocular delivery systems, and other systems for the targeted delivery of injectable therapies.

5 Day Chart for NASDAQ:UNIS

Receive News & Ratings for Unilife Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Unilife Corp and related companies with MarketBeat.com's FREE daily email newsletter.